Gain access now
2022 Vizient biosimilar survey
The recent Vizient provider Biosimilar Survey indicated perspectives on the current landscape of biosimilars and what to anticipate with formulary changes in 2023 and beyond.
- Approvals and what’s next
- Importance of interchangeability and substitution
- Role of payers in the adoption process